BETIFISOLIMAB
UNII V7XRB4BO26

Substance Identification & Data

This profile provides standardized clinical and technical data for Betifisolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V7XRB4BO26.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2460539-60-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

V7XRB4BO26

CAS Registry Number

2460539-60-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BETIFISOLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C155931

National Cancer Institute reference terminology for clinical and research data.

INN ID

11926

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Betifisolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BETIFISOLIMAB

Common Names & Synonyms

BETIFISOLIMAB [INN]

HUMANIZED PD-L1 ANTIBODY (MSB2311)

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN-MUS MUSCULUS MONOCLONAL MSB2311 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MSB2311 .KAPPA.-CHAIN, DIMER

MSB 2311 [WHO-DD]

MSB2311-HUMANIZED PD-L1 ANTIBODY